GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for gut complication after stem cell transplant
Disease control TerminatedThis study tested a drug called apraglutide in 31 people who had severe gut graft-versus-host disease (GVHD) after a stem cell transplant and did not respond to steroids. The goal was to see if the drug is safe and helps control the disease. The trial was stopped early, so result…
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: VectivBio AG • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
Blood cancer transplant study tests blood pressure drug to prevent dangerous immune reaction
Disease control TerminatedThis study tested whether the blood pressure drug telmisartan could prevent acute graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers like leukemia or lymphoma. About 32 participants were enrolled, but the trial was stopped early. The mai…
Matched conditions: GVHD
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 08, 2026 12:02 UTC